Status:
COMPLETED
Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver
Lead Sponsor:
Rush University Medical Center
Conditions:
Hepatocellular Carcinoma
Metastatic Carcinoma to the Liver
Eligibility:
All Genders
18+ years
Brief Summary
This project investigates the feasibility of assessing the relative blood volume of carcinomas in patients with Hepatocellular Carcinoma (HCC) and liver metastases from pancreatic or colorectal cancer...
Detailed Description
This project will enroll patients with non-diffuse liver disease who are candidates for chemo or radioembolization to treat or manage the disease during an image guided intervention. Subjects will und...
Eligibility Criteria
Inclusion
- HCC or metastatic liver disease
- Candidate for radioembolization or chemoembolization
Exclusion
- Pregnant
- Iodine allergy
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT02288910
Start Date
November 1 2014
End Date
July 1 2020
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612